focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS: Riverstone Credit stays stable, Bloomsbury hails record half

Thu, 26th Oct 2023 18:12

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Wednesday and Thursday, and not separately reported by Alliance News:

----------

Riverstone Credit Opportunities Income PLC - London-based energy infrastructure and energy transition credit investor - Net asset value at September 30 was USD1.07, unchanged from June 30. Says this stability was due to continued strong portfolio performance during the third quarter of 2023, and that as of September 30 it is nearly fully invested based on the revolving credit facility added in the fourth quarter last year and on current portfolio commitments. Riverstone Credit says it remains extremely well positioned due to its portfolio of accredited energy-transition focused investments through green or sustainability-linked structured loans. Notes "backdrop of strong energy market performance, the global focus on decarbonisation and the company's unique focus on short duration lending."

----------

Bloomsbury Publishing PLC - London-based publisher - Pretax profit for the half year ended August 31 was up 8% to GBP14.0 million from GBP12.9 million the year before. Says revenue increased 11% to GBP136.7 million from GBP122.9 million, and diluted earnings per share rose 11% to 13.66 pence from 12.30p. Consumer revenue grew 17% to GBP89.4 million, Adult Trade revenue rose 8% to GBP27.6 million and Children's Trade revenue grew 22% to GBP61.7 million. Declares interim dividend of 3.70p per share, more than double 1.41p the prior year. Cash at August 31 totalled GBP39.1 million, down from GBP41.5 million on the same day in 2022. Says it is confident it will achieve market expectations for the year ending February 29 2024, meaning revenue of GBP273.1 million and profit before tax and "highlighted items" of GBP32.5 million.

----------

Schroder Income Growth Fund PLC - UK-based investment company - Lifts dividend for the year ended August 31 by 4.6% to 13.80p per share from 13.20p the year before. Net asset value total return was positive 4.2%, underperforming against positive 5.2% from the FTSE All Share Total Return index. NAV per share decreased to 293.58p from 295.26p. Says many challenges "look set to continue into the year ahead."

----------

Haydale Graphene Industries PLC - Carmarthenshire, Wales-based technology solutions company - Pretax loss for the year ended June 30 widens to GBP6.6 million compared with GBP5.2 million the previous year. Revenue increased 48% to GBP4.3 million from GBP2.9 million, with US sales continuing to progress on "growth in the core aerospace and automotive markets". Administrative expenses increased 13% to GBP6.3 million from GBP5.5 million. Non-Executive Chair David Banks says: "We have made important progress in our next planned steps as a business by forging commercial partnerships and collaborations with leading organisations...the board remains confident that the company will be able to take advantage of the traction it is now seeing."

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says that in six months ended July 31, pretax loss widened to GBP6.6 million from GBP4.5 million the previous year. Revenue fell 46% to GBP160,000 from GBP295,000. Chief Executive Officer Ali Mortazavi says: "Despite a severe macroeconomic climate, we have made significant progress during the past six months...we have been able to translate our computational analyses into tangible assets, generating compelling preclinical data at a fraction of the R&D spend of any competitor." Research & development expenditure increased to GBP5.3 million from GBP3.1 million. Company expects higher "underlying cash burn" in the current half year due to its "planned increase in R&D spend to continue the expansion of our AI capabilities and progress the identification and execution of preclinical targets, together with sustaining our active IP strategy as novel inventions are generated."

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 Aug 2022 13:29

Eight new patent applications filed by e-therapeutics

(Sharecast News) - Computational drug discovery and development company e-therapeutics announced the filing of eight further patent applications in the United States on Monday, to protect innovation arising from its proprietary 'GalNAc-siRNA' technology.

Read more
12 Jul 2022 15:39

UK shareholder meetings calendar - next 7 days

Wednesday 13 July 
Asiamet Resources LtdAGM
Esken LtdAGM
LondonMetric Property PLCAGM
Mycelx Technologies CorpAGM
Oilex LtdGM re name change to Synergia Energy
Steppe Cement LtdAGM
Thursday 14 July 
BT Group PLCAGM
Dr Martens PLCAGM
Great Western Mining Corp PLCAGM
Helical PLCAGM
Mind Gym PLCAGM
Personal Assets Trust PLCAGM
Randall & Quilter Investment Holdings LtdAGM
RS Group PLCAGM
Triple Point VCT 2011 PLCAGM
Vietnam Enterprise Investments LtdAGM
Friday 15 July 
Aveva Group PLCAGM
DCC PLCAGM
DP Poland PLCAGM
Griffin Mining LtdAGM
MC Mining PLCGM re subscription
Monday 18 July 
Audioboom Group PLCAGM
JPMorgan European Discovery Trust PLCAGM
Tuesday 19 July 
Biotech Growth Trust PLCAGM
Clean Power Hydrogen PLCAGM
e-Therapeutics PLCAGM
Norcros PLCAGM
Ten Lifestyle Group PLCGE re commitment to sustainability, B Corp certification
Wynnstay Properties PLCAGM & GM re share buyback
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
4 May 2022 14:11

IN BRIEF: e-Therapeutics doubles annual loss as research costs surge

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Increases loss after investing more in research & development. Pretax loss for the year ended January 31 widens to GBP9.5 million from GBP4.5 million a year ago. Revenue grows to GBP477,000 from GBP317,000.

Read more
27 Apr 2022 16:08

UK earnings, trading statements calendar - next 7 days

Thursday 28 April 
Angle PLCFull Year Results
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
C4X Discovery Holdings PLCHalf Year Results
Checkit PLCFull Year Results
Evraz PLCQ1 Results
Flutter Entertainment PLCQ1 Results
Glencore PLCTrading Statement
Howden Joinery Group PLCTrading Statement
HSS Hire Group PLCFull Year Results
Hurricane Energy PLCFull Year Results
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
International Personal Finance PLCTrading Statement
J Sainsbury PLCFull Year Results
Keystone Law Group PLCFull Year Results
Lancashire Holdings LtdQ1 Trading Statement
Novacyt SAFull Year Results
PPHE Hotel Group LtdTrading Statement
Sanderson Design Group PLCFull Year Results
Schroders PLCTrading Statement
Smith & Nephew PLCQ1 Results
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Standard Chartered PLCQ1 Results
Unilever PLCQ1 Results
Whitbread PLCFull Year Results
Friday 29 April  
Alphawave IP Group PLCQ1 Results
AstraZeneca PLCQ1 Results
Computacenter PLCQ1 Results
Industrials REIT LtdTrading Statement
Kingspan Group PLCTrading Statement
NatWest Group PLCQ1 Results
Nostrum Oil & Gas PLCFull Year Results
Pearson PLCQ1 Results
Reckitt Benckiser Group PLCQ1 Results
Rotork PLCTrading Statement
Smurfit Kappa Group PLCQ1 Results
Travis Perkins PLCQ1 Results
UP Global Sourcing PLCHalf Year Results
Monday 2 May 
no events scheduled 
Tuesday 3 May 
Blackrock Greater Europe Investment Trust PLCHalf Year Results
BP PLCQ1 Results
Camellia PLCFull Year Results
Card Factory PLCFull Year Results
Cardiff Property PLCHalf Year Results
Intelligent Ultrasound Group PLCFull Year Results
Learning Technologies Group PLCFull Year Results
McColl's Retail Group PLCFull Year Results
Wednesday 4 May 
Andrews Sykes Group PLCFull Year Results
Apax Global Alpha LtdTrading Statement
Aston Martin Lagonda Global Holdings PLCQ1 Results
boohoo Group PLCFull Year Results
Dianomi PLCFull Year Results
Direct Line Insurance Group PLCTrading Statement
e-Therapeutics PLCFull Year Results
Flutter Entertainment PLCQ1 Results
International Personal Finance PLCTrading Statement
JD Wetherspoon PLCTrading Statement
Johnson Service Group PLCTrading Statement
OSB Group PLCTrading Statement
Personal Group Holdings PLCTrading Statement
Schroder Oriental Income Fund LtdHalf Year Results
Smiths News PLCHalf Year Results
Tribal Group PLCTrading Statement
UK Commercial Property REIT LtdTrading Statement
WANdisco PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
12 Apr 2022 21:28

TRADING UPDATES: Hornby sales rise; Victoria weathers inflation

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
12 Apr 2022 13:26

E-therapeutics reaches 'key milestone' in Galapagos collaboration

(Sharecast News) - Drug discovery specialist E-therapeutics announced on Tuesday that it has reached a key milestone in its collaboration with Galapagos.

Read more
5 Apr 2022 21:39

TRADING UPDATES: Alpha FX restarts relationship; Atalaya resources up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
22 Nov 2021 15:57

EXECUTIVE CHANGES: All change at Aura Energy amid ASX spin-out plan

EXECUTIVE CHANGES: All change at Aura Energy amid ASX spin-out plan

Read more
22 Nov 2021 14:16

E-therapeutics finance chief stepping down due to family

(Sharecast News) - Drug discovery company E-therapeutics announced on Monday that Karl Keegan was stepping down from his non-board role as chief financial officer, to focus on "extremely difficult" family circumstances in Ireland.

Read more
22 Nov 2021 10:20

eTherapeutics CFO to stand down on 31 December

(Sharecast News) - Drug discovery e-Therapeutics revealed on Monday that chief financial officer Karl Keegan will step down from the role in order to focus on "extremely difficult family circumstances" in Ireland.

Read more
26 Oct 2021 15:36

DIRECTOR DEALINGS: Wise Chair Hinrikus sells GBP81.5 million worth

DIRECTOR DEALINGS: Wise Chair Hinrikus sells GBP81.5 million worth

Read more
26 Oct 2021 14:58

TRADING UPDATES: Strix launches new products; Sylvania profit down

TRADING UPDATES: Strix launches new products; Sylvania profit down

Read more
19 Oct 2021 16:10

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
11 Oct 2021 13:34

IN BRIEF: e-Therapeutics files for five new patents for RNAi platform

IN BRIEF: e-Therapeutics files for five new patents for RNAi platform

Read more
2 Jul 2021 17:37

TRADING UPDATES: ZAIM Credit launches app; Benchmark in Norway boost

TRADING UPDATES: ZAIM Credit launches app; Benchmark in Norway boost

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.